Using mode of action information to improve regulatory decision-making: An ECETOC/ILSI RF/HESI workshop overview

Critical Reviews in Toxicology

Volumn 41, Issue 3, 2011, Pages 175-186

  Carmichael, Neil ^a   Bausen, Melanie ^b   Boobis, Alan R ^c   Cohen, Samuel M ^d   Embry, Michelle ^e   Fruijtier Pölloth, Claudia ^f   Greim, Helmut ^g   Lewis, Richard ^h   Meek, M E ⁱ   Mellor, Howard ^j   Vickers, Carolyn ^k   Doe, John ^h  

^a European Centre for Ecotoxicology and Toxicology of Chemicals   (Belgium)

^b BASF SE   (Germany)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e International Life Sciences Institute   (United States)

^f CATS Consultants GmbH   (Germany)

^g TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^h JEALOTT S HILL INTERNATIONAL RESEARCH CENTRE   (United Kingdom)

ⁱ UNIVERSITY OF OTTAWA   (Canada)

^j ASTRAZENECA   (United Kingdom)

^k WORLD HEALTH ORGANIZATION   (Switzerland)

more..

Author keywords

Biological pathways; chemical categories; chemical risk assessment; human relevance; key events; mode modes of action (MOA MOAs); read across

Indexed keywords

4 HYDROXYPHENYLPYRUVATE DIOXYGENASE; CHOLINESTERASE INHIBITOR; FORMALDEHYDE; PHENOBARBITAL; VINYL ACETATE;

CONSENSUS DEVELOPMENT; DECISION MAKING; ECOTOXICOLOGY; HEALTH HAZARD; MEDICAL SOCIETY; NONHUMAN; REVIEW; RISK ASSESSMENT; TOXICITY TESTING;

ACADEMIES AND INSTITUTES; ANIMALS; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; DECISION SUPPORT TECHNIQUES; ECOTOXICOLOGY; ENVIRONMENTAL POLLUTION; FOUNDATIONS; GOVERNMENT REGULATION; HAZARDOUS SUBSTANCES; HUMANS; RISK ASSESSMENT;

ANIMALIA;

EID: 79952583383     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.3109/10408444.2010.541225     Document Type: Review

References (50)

1. Beane Freeman LE, Blair A, Lubin JH, Stewart PA, Hayes RB, Hoover RN, Hauptmann M. (2009). Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries: The National Cancer Institute Cohort. J Natl Ccaner Inst 101:751-761.
2. Boobis AR, Cohen SM, Dellarco V, McGregor D, Meek ME, Vickers C, Willcocks D, Farland W. (2006). IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit Rev Toxicol 36:781-792. (Pubitemid 44800328)
3. Boobis AR, Doe JE, Heinrich-Hirsch B, Meek ME, Munn S, Ruchirawat M, Schlatter J, Seed J, Vickers C. (2008). IPCS framework for analyzing the relevance of a noncancer mode of action for humans. Crit Rev Toxicol 38:87-96. (Pubitemid 351225507)
4. Butterworth BE. (2006). A classifcation framework and practical guidance for establishing a mode of action for chemical carcinogens. Regul Toxicol Pharmacol 45:9-23.
5. Dellarco VL, Baetcke K. (2005). A risk assessment perspective: Application of mode of action and human relevance frameworks to the analysis of rodent tumor data. Toxicol Sci 86:1-3. (Pubitemid 41511342)
6. ECETOC. (2006). Toxicological Modes of Action: Relevance for Human Risk Assessment. Technical Report No. 99. Brussels: European Centre for Ecotoxicology and Toxicology of Chemicals; July 2006.
7. ECETOC. (2007). Cyanides of Hydrogen, Sodium and Potassium, and Acetone Cyanohydrin. JACC Report No. 53. Brussels: European Centre for Ecotoxicology and Toxicology of Chemicals; September 2007.
8. EU. (2006). Directive 2006/121/ec of the European Parliament and of the Council of 18 December 2006 amending Council Directive 67/548/EEC on the approximation of laws regulations and administrative provisions relating to the classifcation packaging and labelling of dangerous substances in order to adapt it to Regulation (EC) No. 1907/2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) and establishing a European Chemicals Agency.
9. EC (2008). Regulation (EC) No. 1272/ 2008 of the European Parliament and of the Council of 16 December 2008 on classifcation, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC and amending Regulation (EC) No 1907/ 2006.
10. ECB. (2003). Technical Guidance Document in support of Commission Directive 93/67/EEC on risk assessment for new notifed substances, Commission Regulation (EC) No. 1488/94 on risk assessment for existing substances and Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market. Ispra, Italy: European Chemicals Bureau, Institute for Health and Consumer Protection, European Commission Joint Research Centre. Available at: http://ecb.jrc. ec.europa.eu/tgd/available on 5 Jan 2011.
11. ECB (2008). Risk Assessment Vinyl Acetate, CAS-No.: 108-05-4 EINECS-No.: 203- 545-4.
12. Ispra, Italy: European Chemicals Bureau, Institute for Health and Consumer Protection, European Commission Joint Research Centre. Luxembourg: Ofce for Ofcial Publications of the European Communities. Available at: http://ecb.jrc.ec.europa.eu/esis/.
13. Edwards SW, Preston RJ. (2008). Systems biology and mode of action based risk assessment. Toxicol Sci 106:312-318.
14. EFSA. (2005). European Food Safety Authority. Opinion of the Scientifc Committee on a harmonized approach for risk assessment of substances which are both genotoxic and carcinogenic. http://www.efsa.europa.eu/en/scdocs/scdoc/282. htm.
15. European Medicines Agency. (2007). Guideline on Strategies to Identify and Mitigate Risks for First-in Human Clinical Trials with Investigational Medicinal Products. EMEA/CHMP/SWP/28367/07. London: European Medicines Agency.
16. FDA. (2010). US Food and Drug Administration. Guidance for Industry M3(R2). Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals. Washington DC: US Food and Drug Administration.
17. Hall MG, Wilks MF, Provan WM, Eksborg S, Lumholtz B. (2001). Pharmacokinetcs and pharmacodynamics of NTBC (2-(2-nitro-4-fuoromethylbenzoyl)- 1,3-cyclohexanedione) and mesotrione, inhibitors of 4-hydroxyphenyl pyruvate dioxygenase (HPPD) following a single dose to healthy male volunteers. Br J Clin Pharmacol 52:169-177. (Pubitemid 32863075)
18. Hattis D, Chu M, Rahmioglu N, Goble R, Verma P, Hartman K, Kozlak M. (2009). A preliminary operational classifcation system for nonmutagenic modes of action for carcinogenesis. Crit Rev Toxicol 39:97-138.
19. Hill AB. (1965). The environment and disease: Association or causation? Proc R Soc Med 58:295-300.
20. IARC. (1995). International Agency for Research on Cancer. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Dry Cleaning, Some Chlorinated Solvents and Other Industrial Chemicals. 63: Vinyl Acetate. Lyon, France: IARC.
21. IARC. (2006). International Agency for Research on Cancer. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxypropan-2-ol. 88: Formaldehyde. Lyon, France: IARC.
22. ICH. (2005). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. The Non-Clinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals. Guideline S7B. May 2005.
23. ICH. (2009). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Addendum to ICH S6: Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals S6(R1). October 2009.
24. Im H, Oh E, Mun J, Khim JY, Lee E, Kang HS, Kim E, Kim H, Won NH, Kim YH, Jung WW, Sul D. (2006). Evaluation of toxicological monitoring markers using proteomic analysis in rats exposed to formaldehyde. J Proteome Res 5:1354-1366. (Pubitemid 43865806)
25. IPCS (International Programme on Chemical Safety). (2005). Chemical-Specifc Adjustment Factors for Interspecies Diferences and Human Variability: Guidance Document for Use of Data in Dose/Concentration-Response Assessment. Harmonization Project Document No. 2. Geneva: World Health Organization.
26. Johnson MK. (1969). A phosphorylation site in brain and the delayed neurotoxic efect of some organophosphorus compounds. Biochem J 111:487-495.
27. Julien E, Boobis AR, Olin SS. (2009). The Key Events Dose-Response Framework: A cross-disciplinary mode-of-action based approach to examining dose-response and thresholds. Crit Rev Food Sci Nutr 49:682-689.
28. Lambert JC, Lipscomb JC. (2007). Mode of action as a determining factor in additivity models for chemical mixture risk assessment. Regul Toxicol Pharmacol 49:183-194. (Pubitemid 350087394)
29. Lilienblum W, Dekant W, Foth H, Gebel T, Hengstler JG, Kahl R, Kramer P-J, Schweinfurth H, Wollin K-M. (2008). Alternative methods to safety studies in experimental animals: Role in risk assessment of chemicals under the new European Chemicals Legislation (REACH). Arch Toxicol 82:211-236.
30. Lock EA, Gaskin P, Ellis M.K, Provan WM, Robinson M, Smith LL, Prisbylla MP, Mutter LC. (1996). Tissue distribution of 2-(2-nitro-4- trifuoromethylbenzoyl)cyclohexanedione (NTBC): Efect on enzymes involved in tyrosine catabolism and relevance to ocular toxicity in the rat. Toxicol Appl Pharmacol 141:439-447. (Pubitemid 27046370)
31. Lock EA, Smith LL. (2003) The role of mode of action studies in extrapolating to human risks in toxicology. Toxicol Lett 140-141:317-322. (Pubitemid 36378951)
32. Lu K, Collins LB, Ru H, Bermudez E, Swenberg JA. (2010). Distribution of DNA adducts caused by inhaled formaldehyde is consistent with induction of nasal carcinoma but not leukemia. Toxicol Sci 116:441-451.
33. Meek ME. (2009). Mode of Action Frameworks in Toxicity Testing and Chemical Risk Assessment. PhD dissertation, Institute for Risk Assessment Sciences (IRAS), Utrecht University, The Netherlands.
34. Meek ME, Bucher JR, Cohen SM, DeMarco V, Hill RN, Lehman-McKeeman LD, Longfellow DG, Pastoor T, Seed J, Patton DE. (2003). A framework for human relevance analysis of information on carcinogenic modes of action. Crit Rev Toxicol 33:591-654.
35. NRC. (1983). National Research Council: Risk Assessment in the Federal Government. Managing the Process. Washington, DC: National Academy Press.
36. OECD. (2009). Organisation for Economic Co-operation and Development. Guidance on Grouping of Chemicals: Chemical Categories and Read-Across. Available at: http://www.oecd.org/d ocument/6/03343en-2649-34379-43087494-1-1-1- 100.html.
37. OECD. (2002). Organisation for Economic Co-operation and Development. SIDS. Initial Assessment Report: Formaldehyde. Paris: UNEP Publications.
38. SCHER. (2008). Scientifc Committee on Health and Environmental Risks. Risk assessment report on vinyl acetate, human health part. Adopted November 17, 2008. http://ec.europa.eu/health/archive/ph-risk/committees/04-scher/docs/ scher-o-108.pdf.
39. Ross J, Plummer SM, Rode A, Scheer N, Bower CC, Vogel O, Henderson CJ, Wolf CR, Elcombe CR. (2010). Human constitutive androstane receptor (CAR) and pregnane X receptor (PXR) support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogens phenobarbital and chlordane in vivo. Toxicol Sci 116:452-466.
40. Seed J, Carney EW, Corley RA, Crofton KM, DeSesso JM, Foster PM, Kavlock R, Kimmel G, Klaunig J, Meek ME, Preston RJ, Slikker W Jr, Tabacova S, Williams GM, Wiltse J, Zoeller RT, Fenner-Crisp P, Patton DE. (2005). Overview: Using mode of action and life stage information to evaluate the human relevance of animal toxicity data. Crit Rev Toxicol 35:663-672. (Pubitemid 41693589)
41. SIDS. (2002). Screening Information Data Set. Formaldehyde. Paris: UNEP.
42. Sonich-Mullin C, Fielder R, Wiltse J, Baetcke K, Dempsey J, Fenner-Crisp P, Grant D, Hartley M, Knaap A, Kroese D, Mangelsdorf I, Meek E, Rice J, Younes M. (2001). IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul Toxicol Pharmacol 34:146-152. (Pubitemid 33022326)
43. Speit G, Zeller J, Schmid O, Elhajouji A, Ma-Hock L, Neuss S. (2009). Inhalation of formaldehyde does not induce systemic genotoxic efects in rats. Mutat Res 677:76-85.
44. US EPA. (1996). US Environmental Protection Agency. Proposed guidelines for carcinogen risk assessment. Federal Register 61:17960-18011.
45. US EPA. (2005). US Environmental Protection Agency. Guidelines for carcinogen risk assessment. Washington, DC: Risk Assessment Forum. EPA/630/P-03001F. Available at: http://www.epa.gov/raf/publications/pdfs/CANCER- GUIDELINES-FINAL-3-25-05.
46. PDF. US EPA. (2010). IRIS Toxicological Review of Formaldehyde-Inhalation Assessment (External Review Draft). Available at: http://cfpub. epa.gov/ncea/iris-drafts/recordisplay.cfm?deid=223614.
47. Wang M, Cheng G, Balbo S, Carmella SG, Villalta PW, Hecht SS. (2009). Clear diferences in levels of a formaldehyde-DNA adduct in leukocytes of smokers and nonsmokers. Cancer Res 69:7170-774.
48. Williams GM. (2008). Application of mode-of-action considerations in human cancer risk assessment. Toxicol Lett 180:75-80.
49. Yamamoto Y, Moore R, Goldsworthy TL, Negishi M, Maronpot RR. (2004). The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res 64:7197-7200. (Pubitemid 39372050)
50. Zhang L, Steinmaus C, Eastmond DA, Xin XK, Smith MT. (2009). Formaldehyde exposure and leukemia: A new meta-analysis and potential mechanisms. Mutat Res 681:150-168.